Search research articles
Contact Us
Filters
Showing results (121-130 of 150) with videos related to
Page
of 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2000
A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission
S Rodenhuis, R de Wit, P H de Mulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1994
Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size
E van der Wall, D J Richel, M J Holtkamp, et al.
Seminars in Oncology
|
February 1, 1992
Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer Institute
W W ten Bokkel Huinink, O Dalesio, S Rodenhuis, et al.
British Journal of Cancer
|
September 1, 1993
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects
L T Vlasveld, A Hekman, F A Vyth-Dreese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 1999
At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies
A M Westermann, M M Holtkamp, G A Linthorst, et al.
Cancer
|
December 1, 1995
Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support
H van der Lelie, J W Baars, S Rodenhuis, et al.
Blood
|
June 1, 1995
Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation
M W Dercksen, W R Gerritsen, S Rodenhuis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1996
The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis
E van der Wall, C C Schaake-Koning, N van Zandwijk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group
A Le Cesne, I Judson, D Crowther, et al.
Annals of Surgical Oncology
|
April 8, 2010
The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy
M E Straver, E J Th Rutgers, S Rodenhuis, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 150) with videos related to
Sort By:
Page
of 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2000
A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission
S Rodenhuis, R de Wit, P H de Mulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1994
Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size
E van der Wall, D J Richel, M J Holtkamp, et al.
Seminars in Oncology
|
February 1, 1992
Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer Institute
W W ten Bokkel Huinink, O Dalesio, S Rodenhuis, et al.
British Journal of Cancer
|
September 1, 1993
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects
L T Vlasveld, A Hekman, F A Vyth-Dreese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 1999
At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies
A M Westermann, M M Holtkamp, G A Linthorst, et al.
Cancer
|
December 1, 1995
Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support
H van der Lelie, J W Baars, S Rodenhuis, et al.
Blood
|
June 1, 1995
Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation
M W Dercksen, W R Gerritsen, S Rodenhuis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1996
The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis
E van der Wall, C C Schaake-Koning, N van Zandwijk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group
A Le Cesne, I Judson, D Crowther, et al.
Annals of Surgical Oncology
|
April 8, 2010
The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy
M E Straver, E J Th Rutgers, S Rodenhuis, et al.
Page
of 15